Latest News

Market Exclusive Biotech News & Analysis

sarepta srpt

Here’s What Just Happened With Sarepta Therapeutics Inc (NASDAQ:SRPT)

Yet again we've had a big middle of the week in the biotechnology space. Companies have moved on a variety of inputs and we’ve...
Gilead Sciences, In

Gilead Sciences, Inc. (NASDAQ:GILD) HCV Portfolio Strengthened With Vosevi Approval

Gilead Sciences, Inc. (NASDAQ:GILD) traded higher after the Food and Drug Administration (FDA) approved its hepatitis C drug, Vosevi, for patients who have failed...